|

Retatrutide (LY3437943) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Hudson Biotech1

Indications

  • Weight Loss1
  • Obesity1

Other1 trial

Effect of LY3437943 Versus Placebo in Participants Who Have Obesity or Are Overweight
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.